128 related articles for article (PubMed ID: 8391201)
1. Pharmacology of interleukin-1-induced neutrophil migration.
Perretti M; Appleton I; Parente L; Flower RJ
Agents Actions; 1993; 38 Spec No():C64-5. PubMed ID: 8391201
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo.
Matsukawa A; Yoshimura T; Maeda T; Ohkawara S; Takagi K; Yoshinaga M
J Immunol; 1995 May; 154(10):5418-25. PubMed ID: 7730643
[TBL] [Abstract][Full Text] [Related]
5. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia.
Jansen PM; Boermeester MA; Fischer E; de Jong IW; van der Poll T; Moldawer LL; Hack CE; Lowry SF
Blood; 1995 Aug; 86(3):1027-34. PubMed ID: 7620156
[TBL] [Abstract][Full Text] [Related]
6. Bovine neutrophil chemiluminescence is preferentially stimulated by homologous IL-1, but inhibited by the human IL-1 receptor antagonist.
Sample AK; Czuprynski CJ
Vet Immunol Immunopathol; 1994 May; 41(1-2):165-72. PubMed ID: 8066992
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the interleukin-1 beta-induced prostaglandin E2 release from rat hypothalamus is mediated by type I and type II interleukin-1 receptors.
Mirtella A; Tringali G; Guerriero G; Ghiara P; Parente L; Preziosi P; Navarra P
J Neuroimmunol; 1995 Sep; 61(2):171-7. PubMed ID: 7593552
[TBL] [Abstract][Full Text] [Related]
8. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra).
Swiergiel AH; Smagin GN; Johnson LJ; Dunn AJ
Brain Res; 1997 Nov; 776(1-2):96-104. PubMed ID: 9439800
[TBL] [Abstract][Full Text] [Related]
9. The ovarian action of interleukin-1 is receptor mediated: reversal by a naturally occurring interleukin-1 receptor antagonist.
Kokia E; Ben-Shlomo I; Adashi EY
Fertil Steril; 1995 Jan; 63(1):176-81. PubMed ID: 7805908
[TBL] [Abstract][Full Text] [Related]
10. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro.
Catania A; Rajora N; Capsoni F; Minonzio F; Star RA; Lipton JM
Peptides; 1996; 17(4):675-9. PubMed ID: 8804079
[TBL] [Abstract][Full Text] [Related]
11. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
Hattar K; Fink L; Fietzner K; Himmel B; Grimminger F; Seeger W; Sibelius U
J Immunol; 2001 May; 166(10):6287-93. PubMed ID: 11342652
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 beta primes interleukin-8-stimulated chemotaxis and elastase release in human neutrophils via its type I receptor.
Brandolini L; Sergi R; Caselli G; Boraschi D; Locati M; Sozzani S; Bertini R
Eur Cytokine Netw; 1997 Jun; 8(2):173-8. PubMed ID: 9262966
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1.
Perretti M; Flower RJ
J Immunol; 1993 Feb; 150(3):992-9. PubMed ID: 8423349
[TBL] [Abstract][Full Text] [Related]
14. Comparative responses of human and rabbit interleukin-1 in vivo: effect of a recombinant interleukin-1 receptor antagonist.
von Uexküll C; Nourshargh S; Williams TJ
Immunology; 1992 Dec; 77(4):483-7. PubMed ID: 1493919
[TBL] [Abstract][Full Text] [Related]
15. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
16. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse.
Perretti M; Szabó C; Thiemermann C
Br J Pharmacol; 1995 Oct; 116(4):2251-7. PubMed ID: 8564256
[TBL] [Abstract][Full Text] [Related]
17. Infiltration of neutrophils by intrapleural injection of tumour necrosis factor, interleukin-1, and interleukin-8 in rats, and its modification by actinomycin D.
Utsunomiya I; Ito M; Watanabe K; Tsurufuji S; Matsushima K; Oh S
Br J Pharmacol; 1996 Feb; 117(4):611-4. PubMed ID: 8646404
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant interleukin-1 receptor antagonist blocks bone resorption induced by interleukin-1 beta but not interleukin-1 alpha.
Chole RA; Tinling SP; Faddis BT
Calcif Tissue Int; 1994 Jul; 55(1):12-5. PubMed ID: 7922783
[TBL] [Abstract][Full Text] [Related]
19. Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats.
Santos DR; Calixto JB; Souza GE
Br J Pharmacol; 2003 May; 139(2):271-8. PubMed ID: 12770932
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
